Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Glaukos Corporation Common Stock
(NY:
GKOS
)
87.80
+10.71 (+13.89%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Glaukos Corporation Common Stock
< Previous
1
2
3
4
5
6
Next >
Why Glaukos Stock Zoomed Almost 14% Higher on Thursday
Today 18:54 EDT
The company's recent past featured robust growth, and it anticipates continued rises into the near future.
Via
The Motley Fool
Glaukos (GKOS) Q3 2025 Earnings Call Transcript
Today 18:15 EDT
Glaukos (GKOS) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
Today 10:19 EDT
Via
Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
Today 9:30 EDT
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Earnings Scheduled For October 29, 2025
October 29, 2025
Via
Benzinga
Expert Outlook: Glaukos Through The Eyes Of 4 Analysts
September 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Today 8:08 EDT
Via
Benzinga
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
Today 7:36 EDT
Via
Benzinga
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Today 5:38 EDT
Via
Benzinga
Earnings Scheduled For July 30, 2025
July 30, 2025
Via
Benzinga
Earnings Scheduled For April 30, 2025
April 30, 2025
Via
Benzinga
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today
February 24, 2025
Via
Benzinga
Earnings Scheduled For February 20, 2025
February 20, 2025
Via
Benzinga
Why Glaukos Stock Jumped Over 20% After-Hours Today
October 29, 2025
Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance.
Via
Stocktwits
What's going on in today's after hours session
October 29, 2025
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Glaukos Corp (NYSE:GKOS) Soars on Strong Q3 2025 Earnings Beat and Robust 2026 Outlook
October 29, 2025
Glaukos (GKOS) smashed Q3 2025 earnings forecasts, sending its stock soaring. The company posted record revenue and raised its 2025 and 2026 sales guidance.
Via
Chartmill
Topics
Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 29, 2025
Via
Benzinga
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
October 27, 2025
Via
Benzinga
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
October 27, 2025
Via
Benzinga
Expert Outlook: Glaukos Through The Eyes Of 7 Analysts
October 13, 2025
Via
Benzinga
Glaukos (GKOS) Q2 Revenue Jumps 30%
August 01, 2025
Via
The Motley Fool
What 11 Analyst Ratings Have To Say About Glaukos
May 02, 2025
Via
Benzinga
This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
May 01, 2025
Via
Benzinga
Forecasting The Future: 7 Analyst Projections For Glaukos
April 16, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning Glaukos Stock In The Last 5 Years
March 28, 2025
Via
Benzinga
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
February 24, 2025
Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its non-invasive treatment potential.
Via
Benzinga
Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?
February 21, 2025
All three major U.S. stock indices are down Friday as traders reacted to several sets of fresh data that raised concerns about the economic outlook.
Via
Benzinga
Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition
February 21, 2025
Glaukos reported Q4 sales of $105.5 million, surpassing estimates, while EPS missed. Analysts see strong growth potential as the company expands its business model.
Via
Benzinga
Wondering what's happening in today's after-hours session?
February 20, 2025
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
February 19, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.